English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

To describe our initial experience with the novel BioMime™ 60mm-long sirolimus-eluting tapered coronary stent system in patients with long coronary lesions.We included 50 consecutive patients in whom a 60mm-long drug- eluting stent (DES) implantation was attempted due to the presence of coronary lesions longer than 48mm. The 60mm-long DES was successfully implanted in 46 (92%) patients. In 4 patients stent deployment failed due to the impossibility of crossing completely the lesions. During a median follow-up of 275 days [IQR (166-386)], no clinical adverse events (death, myocardial infarction or target lesion revascularization) were observed.The use of the novel BioMime™ 60mm-long DES for the treatment of long coronary lesions exhibits promising results in a relatively short-intermediate follow-up.

Initial experience with the novel BioMime 60 mm-long sirolimus-eluting tapered stent system in long coronary lesions